Article cité par

La fonctionnalité Article cité par… liste les citations d'un article. Ces citations proviennent de la base de données des articles de EDP Sciences, ainsi que des bases de données d'autres éditeurs participant au programme CrossRef Cited-by Linking Program. Vous pouvez définir une alerte courriel pour être prévenu de la parution d'un nouvel article citant " cet article (voir sur la page du résumé de l'article le menu à droite).

Article cité :

Immunothérapie des cancers par oligonucléotides immunostimulants

Antoine F. Carpentier

Med Sci (Paris), 21 1 (2005) 73-77

Publié en ligne : 2005-01-15

DOI: https://doi.org/10.1051/medsci/200521173

Citations de cet article :

Bivalent OX40 Aptamer and CpG as Dual Agonists for Cancer Immunotherapy

Tingting Jiang, Zailin Yang, Qiuyu Su, Liang Fang, Qing Xiang, Cheng Tian, Qinlin Gao, Chengde Mao, Cheng Zhi Huang and Hua Zuo
ACS Applied Materials & Interfaces 17 (5) 7353 (2025)
https://doi.org/10.1021/acsami.4c18550

Immune Modulator and Low-Temperature PTT-Induced Synergistic Immunotherapy for Cancer Treatment

Yue Duan, Han Yang, Junxiao Gao, et al.
ACS Applied Bio Materials 4 (2) 1524 (2021)
https://doi.org/10.1021/acsabm.0c01397

Heterogeneity of Toll-like receptor 9 signaling in B cell malignancies and its potential therapeutic application

Ling Bai, Wei Chen, Jingtao Chen, et al.
Journal of Translational Medicine 15 (1) (2017)
https://doi.org/10.1186/s12967-017-1152-5

The proprotein convertase PC1/3 regulates TLR9 trafficking and the associated signaling pathways

M. Duhamel, F. Rodet, A. N. Murgoci, et al.
Scientific Reports 6 (1) (2016)
https://doi.org/10.1038/srep19360

Radio-immunothérapie alpha

Jérémie Ménager, Jean-Baptiste Gorin, Nolwenn Fichou, et al.
médecine/sciences 32 (4) 362 (2016)
https://doi.org/10.1051/medsci/20163204014

Vectorization of Nucleic Acids for Therapeutic Approach: Tutorial Review

Frederic Geinguenaud, Erwann Guenin, Yoann Lalatonne and Laurence Motte
ACS Chemical Biology 11 (5) 1180 (2016)
https://doi.org/10.1021/acschembio.5b01053

Macromolecular Anticancer Therapeutics

Anne Laure Ramon and Claude Malvy
Macromolecular Anticancer Therapeutics 539 (2010)
https://doi.org/10.1007/978-1-4419-0507-9_16

Synergistic antitumor effects of CpG oligodeoxynucleotide and STAT3 inhibitory agent JSI‐124 in a mouse melanoma tumor model

Ommoleila Molavi, Zengshuan Ma, Samar Hamdy, Raymond Lai, Afsaneh Lavasanifar and John Samuel
Immunology & Cell Biology 86 (6) 506 (2008)
https://doi.org/10.1038/icb.2008.27

Pretransplant treatment of donors with immunomodulators to control graft-versus-host disease (GVHD) in transplant recipients

Shoshana Morecki, Elena Yacovlev, Yael Gelfand, Osnat Eizik and Shimon Slavin
Experimental Hematology 35 (5) 748 (2007)
https://doi.org/10.1016/j.exphem.2007.01.050

Immune Mechanisms and Therapeutic Potential of CpG Oligodeoxynucleotides

Heather L. Wilson, Arshud Dar, Scott K. Napper, et al.
International Reviews of Immunology 25 (3-4) 183 (2006)
https://doi.org/10.1080/08830180600785868